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Background: There are investigations concluding that reduced vitamin D status in pregnancy,
may be a risk factor for the development of allergic outcomes in offspring.
However, studies on the relationship between cord levels of 25-hydroxyvitamin D (25[OH]D)
and risk of early childhood wheezing and early-onset atopic dermatitis/food allergy are very
limited.
Objective: To assess the associations between cord blood concentration of 25[OH]D and occur-
rence of the incidence of wheezing, atopic dermatitis, food allergy, during the first two years
of life.
Methods: We evaluated 240 children by the age of 2 years from the Polish Mother and Child
Cohort Study. Women were interviewed during pregnancy to collect demographic and socio-
economic data, the medical and reproductive history. At delivery, umbilical cord blood plasma
was sampled. The child’s health status were examined at approximately 2 years. In the ana-
lyses multivariable model was used.
Results: Data from 190 participants were included into the analysis. The median value and
quartile range of 25[OH]D in cord blood [ng/ml] were as follows: 6.33, 4.16e8.53.
25[OH]D in cord blood below lower quartile increases the risk of multi-triggered wheezing
(MTW) in children during first 2 years of life (OR: 2.81; 95% CI: 1.13e7.00). Higher cord serumitamin D; GPx3, glutathione peroxidase; ISAAC, International Study of Asthma and Allergies in
environmental factors and their Influence on Newborns Allergy Risk Study; MTW, multi-triggered
sh Mother and Child Cohort Study; RSV, respiratory syncytial virus; RTIs, respiratory tract infections;
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Early childhood viral-induced wheezing 39level of 25[OH]D reduces the risk of viral induced wheezing (VIW). The cord serum level of 25
[OH]D below median value (OR: 6.06; 95% CI: 1.3e28.3) or below lower quartile (OR: 5.43;
95% CI: 1.66e17.7) increases the risk of VIW. All above effects of vitamin D level in cord blood
were corrected for the effects other independent risk factors of wheezing and VIW in this
cohort.
Conclusions: Cord serum 25[OH]D levels were inversely associated with the risk of multi-
triggered wheezing, and especially viral-induced wheezing by the age of 2 years, but no asso-
ciation was found with food allergy, atopic dermatitis and frequencies of infections.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
As the main pathways of the vitamin D metabolism in the
body have been well known from years, the recently re-
ports and investigations emphasize the role of this vitamin
as a new potential immunoregulator of biological functions
with a particular role in immune tolerance and further, as
a risk factor to the development of allergic diseases. Never
the less prospective and randomized studies on the
Vitamin D influence and allergic disorders are lacking. The
body of epidemiological evidence in relation to nutrients
and dietary factors for the prevention of asthma and
allergic diseases is overall weak, never the less, suggestive
in relation to vitamins A, D, vegetables, microelements
and Mediterranean diet, particularly in relation to asthma
[1,2]. There are also investigations concluding that
reduced vitamin D status in pregnancy, respectively in
umbilical cord plasma of the newborn, may be a risk factor
for the development of atopic dermatitis in the first year
of life [3].
It is known that innate immunity and especially regula-
tory T cells are presumed to play an essential role in the
development of adaptive immunity, allergy or asthma in
early life [4] but in the other hand recent researches have
highlighted that these processes are strongly influenced by
serum vitamin D level [5]. It has been also proved In LINA
study an association between the number of cord blood
regulatory T cells and the occurrence of sensitizations
against food allergens later in life [6]. Until this date there
are limited studies deliberating the parental vitamin D
status and its impact on the newborn immune status and
later infantile outcomes. Concerning the importance of the
vitamin D level in newborns and subsequent immune
changes, it appears that more reliable investigations are
required. Over the last few years there were multiple
studies investigating the effects of maternal vitamin D
intake and cord blood 25[OH]D level in newborn on the
inception of asthma and allergy diseases, never the less the
results are contradictory.
Our aim was to assess the associations between cord
blood 25[OH]D level and occurrence of the incidence of
wheeze, atopic dermatitis, food allergy, frequency of in-
fections during the first two years of life. In a previous
report on this cohort [1], we found associations between
zinc/cooper concentrations in cord blood and prevalence of
wheezing during the 1st year of life and between lower
activity of glutathione peroxidase (GPx3) in cord blood andatopic dermatitis in studied children; consequently these
variables are included as a confounders in the current
analysis.
Methods
Study design and population
The Polish Mother and Child Cohort Study (REPRO_PL
cohort) was established in 2007; the cord blood plasma was
analyzed in 240 participants. A complete description of the
methodological assumptions has been published elsewhere
[1,7,8]. Women were recruited at maternity units during
the first trimester of pregnancy if they fulfilled the
following inclusion criteria: a single pregnancy of up to 12
weeks of gestation, no assisted conception, no pregnancy
complications, and no chronic diseases, as specified in the
study protocol. Women were interviewed three times dur-
ing pregnancy to collect demographic and socioeconomic
data, the medical and reproductive history. Exposure to
tobacco constituents was assessed based on questionnaire
data (full description of assessment of children’s exposure
to tobacco smoke was published elsewhere) [7,8]. At de-
livery, infant (umbilical cord blood) plasma were sampled.
One year after the child’s birth, an invitation letter was
sent to mothers participating in the REPRO_PL cohort,
proposing to have the child’s exposure and health status
examined. Within the next two weeks, a telephone call was
made to schedule a mother-and-child visit at the medical
centre for an examination by a pediatrician/allergologist.
The current analysis is restricted to 240 children by the
age of 2 years, in whom cord blood plasma was previously
analyzed. All parents or guardians of the patients gave their
written consent before the study. The study was approved
by the Ethical Committee of the Nofer Institute of Occu-
pational Medicine, Ło´dz, Poland (Decision No. 7/2007 and
3/2008). The study was registered on: www.ClinicalTrials.
gov, NCT01861548.
Child health assessment
Children’s health status was assessed at approximately 24
months of age (range, 23e30 months). For the appropriate
recognition of children’s health status, a questionnaire was
administered to the mothers and supplemented with in-
formation from the medical chart of each child. The testing
Table 1 Description of the study cohort.
Variable Statistics
Clinical profile: n (%)
Atopic dermatitis 24 (12.6)
Food allergy 36 (22.4)
Multi-triggered wheezing 22 (11.7)
Viral-induced wheezing 13 (8.2)
Inhaled corticosteroid use 35 (22.8)
Participants with infection 62 (39)
Infection ratea 1.4
Family status:
Parental atopy, n (%), 71 (41.8)
Mother’s age [year] mean  SD 29.5  4.1
Maternal education
Primary, n (%) 9 (4.8)
Secondary, n (%) 52 (27.8)
University, n (%) 126 (67.4)
Father’s age [year] mean  SD 32.1  5.4
Paternal education
Primary, n (%) 32 (17.2)
Secondary, n (%) 68 (36.6)
University, n (%) 86 (46.2)
Worse financial situation, n (%) 22 (13.1)
Children’s environment tobacco smoke:
Maternal smoking, n (%) 28 (15)
Paternal smoking, n (%) 71 (37.8)
Parental smoking, n (%) 80 (43.0)
Cotinine in saliva during
pregnancy [ng/ml],
median (quartile range)
0.91 (0.57e1.52)
Children’s cotinine in urine [ng/ml],
median (quartile range)
3.49 (1.78e8.89)
a Total number of infection/participant/12 months.
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ence of the mother or a relative.
The first part of the questionnaire covers certain socio-
demographic information (i.e. family size, material status
of the family, and parental educational level). The second
part of the questionnaire investigates the child’s health and
condition. The incidence of upper and lower respiratory
tract infections (RTIs) and any symptoms of allergy to food
and inhalant allergens are noted. Infections were defined
as episodes of cold without wheezing. The data provided by
the mothers is supplemented with the use of information
from the medical chart of each child. The duration of each
infection and disease, medications taken, and hospitaliza-
tions, if any, are identified. Special attention is paid to the
identification of any signs and symptoms of allergy and
asthma. This part of the questionnaire has been developed
by an allergologist, based on recommendations from the
International Study of Asthma and Allergies in Childhood
(ISAAC) [9]. Patients were defined as having food allergy or
atopic dermatitis if they had ever been diagnosed by a
physician. In addition, the occurrence of allergy among
family members was noted.
Viral-induced wheezing (VIW) in childhood was defined
as wheeze ever appearing during infection.
Multi-triggered wheezing (MTW) was defined as
wheezing triggered by two or more factors (e.g., viral
infection, weather, activity).
Cord serum 25[OH]D measurement
Immediately after delivery, cord blood serum samples were
collected by midwives. Blood samples were centrifuged
within 24 h of collection. The serum was separated it was
stored at 80 C.
25[OH]D level was determined in cord plasma using HPLC
commercial kit producedbyChromosystemsR (no38038). This
method applies proteins precipitation and solid phase
extraction of interfering components in simple HPLC isocratic
method.Chromatogramsaredetectedby anUVdetector. The
analyses are quantified by the inclusion of a stable internal
standard and results are calculated by the integration of the
peak area using external standard method.
Statistical analysis
The associations between presence of: i) atopic dermatitis,
ii) food allergy, >1episode of respiratory tract infection, iii)
at least 1 episode of multi-triggered wheezing (MTW), iv) at
least 1 episode viral-induced wheezing (VIW) (defined as
dependent variables) and 25[OH]D level (defined as inde-
pendent variable) were assessed by logistic regression.
Vitamin D level in cord blood was included as continues
variable (log-transformed before analysis) or as nominal
variable (defined in two different cut-offs < median and
<lower lower quartile). The effect of vitamin D was cor-
rected for the effects of other independent risk factors of
dependent variable, defined previously in this cohort [1].
First, logistic regression was used to assess the relationship
between dependent variables and each of the independent
variables (presented in Table 1). A stepwise forward pro-
cedure was then used to select variables. Predictors with p-levels of at least 0.1 estimated in univariate models were
included into multivariate regression analyses. All of the
statistical analyses were performed using SPSS 11.5. The
null hypothesis was rejected if p < 0.05.
Results
Data from 190 participants were included into the analysis.
Description of the study cohort is given in Table 1. Among
all studied children 39 (24.5%) had at least one curse of
antibiotic; 6 (5.9%) were hospitalized. Median value and
quartile range of 25[OH]D in cord blood [ng/ml] were as
follows: 6.33, 4.16e8.53. Individual values are presented in
Fig. 1A.
We have assessed the association between low 25[OH]D
and ICS treatment. Vitamin D <median lower quartile in-
creases prevalence of ICS treatment, however it did not
reached the level of significance: OR Z 1.89; 95%CI:
0.85e4.22; p Z 0.117.
MTW during first two years of life was observed in 8.5% vs
14.9% of children when 25[OH]D in cord blood was above vs
below median value (Fig. 1B) and in 8.6% vs 20.8% of chil-
dren when 25[OH]D in cord blood was above vs below lower
quartile (Fig. 1C).
Figure 1 Vitamin D level in cord blood for each participants
(median value and quartile range are presented) (A), associa-
tion between multi-triggered wheezing (MTW) (left panel) and
viral-induced wheezing (VIW) (right panel) and vitamin D in
cord blood dichotomized in median value (B) and association
between MTW (left panel) and VIW (right panel) and vitamin D
in cord blood dichotomized in 25 percentile (C).
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13.8% of children when 25[OH]D in cord blood was above vs
below median value (Fig. 1B) and in 4.3% vs 19.5% of chil-
dren when 25[OH]D in cord blood was above vs below lower
quartile (Fig. 1C).
We showed that 25[OH]D in cord blood is associated with
wheezing during first 2 years of life. 25[OH]D in cord blood
below lower quartile increased the risk of MTW in children
during first 2 years of life (Table 2). Importantly, this as-
sociation was more clear for VIW. We observed that higher
concentration of 25[OH]D in cord blood reduced the risk ofVIW in children during first 2 years of life. However, 25[OH]
D in cord blood below median value or below lower quartile
increased the risk of VIW in children during first 2 years of
life (Table 2). All above results of 25[OH]D level in cord
blood were corrected for the effects of other independent
risk factors for MTW and VIW in this cohort. Odds ratios
describing associations between MTW or VIW and 25[OH]D
were adjusted for the number of infections and paternal
smoking. Adjustments were allowed by multivariate logistic
regression analysis.Discussion
Our study shows that vitamin D status is inversely related to
wheezing as a symptom of viral infections in early child-
hood. MTW, and especially VIW by the age of 2 years, were
associated with low 25[OH]D level in cord blood. This as-
sociation was independent from the frequency of infections
and other risk factors of wheeze, including paternal
smoking and exposure to smoke during pregnancy and
infancy.
It seems that 25[OH]D does not prevent the infections
themselves but it prevents wheezing as the symptom of
viral infection. 25[OH]D has an important role in the control
of inflammatory responses. Regulatory T-cells mediate this
control. Studies have shown that infectious diseases occur
due to dysfunction of regulatory T-cells related to 25[OH]D
deficiency [10,11]. T-reg’s role in the inflammatory disease
of the infancy period has been shown in different clinical
trials to be strongly related to 25[OH]D deficiency (e.g.
wheezy infant) [12,13]. Studies have shown that cord serum
25[OH]D levels are inversely associated with the risk of
transient early wheezing [14], lower respiratory tract in-
fections [15]. Recent findings by Łuczynska et al. [16]
suggest that vitamin D deficiency at birth is associated
with increased risk of lower respiratory tract infections
particularly in infants born to mothers without allergy. This
was not confirmed by our study. We believe that this
discrepancy could be a result of lower level of 25[OH]D in
our cohort, Łuczynska et al. studied 25[OH]D as categorized
variable with cut-offs higher than ours. From statistical
point of view it could explained different results. Camargo
et al. have shown that increased maternal intake of 25[OH]
D during pregnancy may reduce wheeze risk in offspring at 3
years of age [17]. In that study, compared to children of
mothers in the lowest quartile of vitamin D intake during
pregnancy (median, 356 IU/day), children of mothers in the
highest vitamin D intake quartile (median, 724 IU/day) had
a significant lower risk of recurrent wheeze [17,18].
Devereux et al. reported similar findings e an inverse as-
sociation between maternal vitamin D intake during preg-
nancy and risk of recurrent wheezing in 5-year-old children
[19]. In other study Balderbos et al. revealed an association
between lower vitamin D status in newborn and increased
risk of infant RSV-associated pulmonary infections and
further wheezing [20]. According to their findings infants
who contracted an RSV-associated infection had signifi-
cantly lower cord blood 25[OH]D concentrations at birth
than infants who did not develop infection. It should be
noted that cord blood level of 25[OH]D in our cohort was
different (much lower) to those of ex. Baiz et al. [14],
Table 2 Associations between presence of: i) atopic dermatitis, ii) food allergy, >1episode of respiratory tract infection, iii)
at least 1 episode of multi-triggered wheezing (MTW), iv) at least 1 episode viral-induced wheezing and vitamin D level in cord
blood (included in the model as continues variable or included in the model as nominal variable: <median or < lower-quartile).
Dependent variables: D3 continues variableb D3<median value D3<lower quartile
OR 95% CI p OR 95% CI p OR 95% CI p
Atopic dermatitis 0.97 0.86e1.10 0.6608 0.68 0.29e1.62 0.3843 0.98 0.37e2.64 0.9747
Food allergy 2.72 0.43e17.29 0.2887 0.64 0.30e1.35 0.2410 0.93 0.40e2.18 0.8662
Infection >1episod 1.52 0.33e6.94 0.5898 1.13 0.60e2.15 0.6976 0.95 0.46e1.96 0.8893
MTWa 0.20 0.02e1.71 0.1419 1.88 0.75e4.72 0.1784 2.81 1.13e7.00 0.0269
Viral-induced wheezinga 0.05 0.00e0.81 0.0349 6.06 1.30e28.30 0.0220 5.43 1.66e17.72 0.0051
Significance for bold values is p > 0.05.
a The effect of vitamin D level in cord blood is corrected for the effects of other independent risk factors of multi e triggered wheezing
(MTW) and viral induced wheezing in this cohort: number of infection and paternal smoking.
b Odds ratios for each ng/ml increase in vitamin D.
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confirms previous observation that Vitamin D deficiency is
frequent among Polish population [21]. It seems that
although the current Polish recommendations [22] suggest
vitamin D supplementation for prophylactic in infants
including pregnant and lactating women, this is not effec-
tive, probably because Vitamin D is very often given only
occasionally, if at all. The evident consequence is low
average 25[OH]D level among populations of Central
Europe, including our cohort.
On the other hand, the most dynamic lung development
is in the prenatal period. It could be that the lung devel-
opment in the conditions of high concentration of vitamin
D3 prevents wheezing at first two years of life. Our result is
supported by other studies. Zosky et al. in their study
showed that 25[OH]D deficiency during lung development
may impact on postnatal lung growth and increase the risk
of developing lung disease [23]. Other authors state that 25
[OH]D also regulates genes involved in the inflammation,
immunity, cellular proliferation, and apoptosis associated
with obstructive airways disease, likely via a genetic
mechanism and that 25[OH]D deficiency directly affects
programming within the developing fetal lung [24e26]. It is
difficult to completely assess the role 25[OH]D plays in the
development of wheezing. In order to further delineate a
possible correlation between 25[OH] D and asthma/
wheezing, large and prospective studies need to be
conducted.
In the light of several conflicting hypothesis, 25[OH]D
levels have been both positively and negatively correlated
with allergic disease prevalence. For example, high asthma
prevalence and increased asthma symptoms have been
observed in patients with low 25[OH]D levels [18,27e34].
Recently, vitamin D deficiency has been shown to correlate
with many food and environmental allergies in children
[35]. Studies have shown that cord serum 25[OH]D levels
are inversely associated with atopic dermatitis by the age
of 5 years [14], but no association was found with asthma
and allergic rhinitis [14]. Conversely, other studies have
shown an association between high 25[OH]D levels and the
development of allergic diseases [16,36]. What is more,
Xystrakis et al. showed evidence that 25[OH]D may have a
therapeutic role in asthma by enhancing responsiveness to
glucocorticosteroids for induction of il-10 [37]. Chi et al.have shown that higher vitamin D levels at birth may be
associated with a low number of T-regulatory cells
concluding that vitamin D status in utero may influence
immune regulation in early life [5].
The small sample size is one of the limitations of our
study. Other limitation of the study is the reliance on a
single 25[OH]D measurements per subject. More reliable
results would be acquired if we could measure 25[OH]D
levels during the subsequent years of life. It seems also that
it is important to establish the vitamin D supplementation
in the investigated population of children, the way of
feeding and sun-exposure.
In conclusion, our data revealed an inverse correlation
between cord serum 25[OH]D levels and multi-triggered
wheezing, and especially viral-induced wheezing by the age
of 2 years. This suggests that improving the 25[OH]D status
of children and pregnant women must be included in the
priorities of physicians and healthcare professionals
Adequate Vitamin D intake and its optimal concentration in
serum may reduce the risk of multi-triggered wheezing,
especially of viral-induced wheezing.
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